Category

Press Release
•2019年5月10日

Predicine Partners with FMD to Accelerate Biomarker-Driven Clinical Trials and Regulatory Approvals in the U.S. and China

Predicine today announced a strategic partnership with ...
•2018年12月3日

Congruence Study Between Two ctDNA Liquid Biopsy Testing in mBC Patients and Prognostic Value in Combination with CTCs, Investigators to Report at SABCS 2018

Liquid biopsies are being widely studied as a minimally...
•2018年10月18日

Predicine Establishes Dual CAP Accreditation for its Genomic Sequencing Laboratories in US and China to Support Global Clinical Trials

Predicine, a molecular insights company, announced toda...
•2018年9月20日

Predicine and Flagship Biosciences Partner to Support Global Biomarker Development

Predicine and Flagship Biosciences are excited to annou...
•2018年8月22日

Predicine and Kintor Pharma to Present ctDNA & ctRNA Biomarker Data for PhI/II Clinical Trial in mCRPC at ESMO 2018

Predicine and Kintor Pharma today announced that new da...
•2018年7月3日

Predicine and Kintor Pharmaceuticals Collaborate on Precision Oncology Clinical Trials and Companion Diagnostics Development

Predicine, a precision medicine company based in Silico...
•2018年4月30日

Predicine Launches PredicineATLAS, a 600-gene Blood-based TMB Panel to Accelerate Immuno-oncology Clinical Trials

Hayward, Calif., April. 30, 2018 — Predicine toda...
•2018年4月16日

Predicine Closes Series A Financing Totaling $13.5M

Predicine, a Hayward, Calif.-based precision medicine c...
1 … 18 19 20